Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Flu, Avian”

214 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 214 results

Early research (Phase 1)Study completedNCT02295813
What this trial is testing

Safety and Pharmacokinetics Study of FBF001

Who this might be right for
Avian Influenza
Fab'entech 16
Testing effectiveness (Phase 2)UnknownNCT02095444
What this trial is testing

Using Human Menstrual Blood Cells to Treat Acute Lung Injury Caused by H7N9 Bird Flu Virus Infection

Who this might be right for
Acute Lung InjuryAcute Respiratory Distress Syndrome (ARDS)Multiple Organ Failure
S-Evans Biosciences Co., Ltd. 20
Early research (Phase 1)Study completedNCT03330899
What this trial is testing

Safety and Immunogencity of H7N9 Influenza Antigen With 2 Adjuvant Formulations in Healthy Adults in Brazil

Who this might be right for
InfluenzaH7N9 Influenza
Butantan Institute 432
Testing effectiveness (Phase 2)Study completedNCT01416571
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Monovalent Pandemic H5N1 Vaccine in Adults

Who this might be right for
Influenza
GlaxoSmithKline 78
Testing effectiveness (Phase 2)Study completedNCT00311675
What this trial is testing

St. Jude Open Label H5 Trial

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 35
Large-scale testing (Phase 3)Study completedNCT01788228
What this trial is testing

Safety and Tolerability Study of GlaxoSmithKline (GSK)1557484A Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure

Who this might be right for
InfluenzaInfluenza Vaccines
GlaxoSmithKline 50
Early research (Phase 1)Study completedNCT01511419
What this trial is testing

Safety Trial of Live Attenuated Influenza (H7N3) Vaccine

Who this might be right for
InfluenzaAvian Influenza
PATH 40
Testing effectiveness (Phase 2)Study completedNCT00771615
What this trial is testing

Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged 18-64 Years

Who this might be right for
Influenza
GlaxoSmithKline 469
Testing effectiveness (Phase 2)Study completedNCT00240968
What this trial is testing

H5 Booster After a Two Dose Schedule

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 337
Early research (Phase 1)Study completedNCT00664417
What this trial is testing

Study of Different Formulations of an Intramuscular A/H5N1 Inactivated, Split Virion Influenza Adjuvanted Vaccine

Who this might be right for
InfluenzaOrthomyxoviridae Infections
Sanofi 375
Early research (Phase 1)Study completedNCT00660257
What this trial is testing

Safety and Immunogenicity of Booster Dose of An Inactivated,Adjuvanted Whole-Virion Pandemic Influenza(H5N1)Vaccine

Who this might be right for
Pandemic Influenza VaccinePreventionPandemic Influenza
Sinovac Biotech Co., Ltd 57
Large-scale testing (Phase 3)Study completedNCT00462215
What this trial is testing

Phase 3 Immunogenicity and Safety Study of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)

Who this might be right for
Influenza
Alachua Government Services, Inc. 550
Testing effectiveness (Phase 2)Study completedNCT00814385
What this trial is testing

Immunogenicity of Adjuvanted or Non-adjuvanted H5N1 Booster Vaccine in Adults Primed to A/VN/1194/04

Who this might be right for
Influenza
University Hospitals, Leicester 606
Testing effectiveness (Phase 2)Study completedNCT00230750
What this trial is testing

Inactivated Influenza A/H5N1 Vaccine in the Elderly

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 261
Large-scale testing (Phase 3)Study completedNCT02107807
What this trial is testing

Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Immunosuppressive Conditions *aH5N1:Monovalent H5N1 Influenza Vaccine

Who this might be right for
Influenza, HumanFlu, HumanFlu, Avian+2 more
Seqirus 539
Early research (Phase 1)Study completedNCT00309647
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of Pandemic Monovalent (H5N1) Influenza Vaccines (Whole Virus Formulation) in Adults 18 and 60 Years of Age

Who this might be right for
Influenza
GlaxoSmithKline 400
Testing effectiveness (Phase 2)Study completedNCT00841646
What this trial is testing

Safety and Immunogenicity of Two Doses of Monovalent Inactivated Influenza Vaccine That is Adjuvanted With MF59C.1 (MF59) and Uses a Surface Antigen From a Potential Pandemic Virus Strain Candidate (H5N1) in Adult and Elderly Subjects

Who this might be right for
Prepandemic Influenza Vaccine
Novartis Vaccines 343
Testing effectiveness (Phase 2)Study completedNCT01938742
What this trial is testing

H7N9 Mix and Match With MF59 in Healthy Adults

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 700
Testing effectiveness (Phase 2)Study completedNCT03589807
What this trial is testing

2013/2017 H7N9 Prime-Boost Interval

Who this might be right for
Avian InfluenzaInfluenza Immunisation
National Institute of Allergy and Infectious Diseases (NIAID) 180
Testing effectiveness (Phase 2)Study completedNCT01323946
What this trial is testing

Study to Evaluate the Immunogenicity and Safety of an Investigational Pandemic Influenza Vaccine in Children

Who this might be right for
Influenza
GlaxoSmithKline 113
Next Page